Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18889148 | 0.81 | PTPN22 (0.48) | PTPN22LDHAMAPTTDP1CYP1A2 | |
| SCHEMBL22284140 | 0.78 | PTPN22 (0.58) | PTPN22LDHAMAPTTDP1CYP1A2 | |
| SCHEMBL18650742 | 0.78 | NCEH1 (0.51) | L3MBTL1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27607719 | 0.78 | NCEH1 (0.53) | ERN1L3MBTL1MAPTNPC1RAB9A | |
| SCHEMBL20179452 | 0.78 | LMNA (0.51) | ERN1L3MBTL1MAPTNPC1RAB9A | |
| SCHEMBL30657140 | 0.78 | NCEH1 (0.53) | ERN1L3MBTL1MAPTNPC1RAB9A | |
| SCHEMBL2946 | 0.76 | ALDH1A1 (0.47) | L3MBTL1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8130488 | 0.76 | LDHA (0.45) | LDHACYP1A2CYP2C9CYP2C19ABCG2 | |
| SCHEMBL17291109 | 0.75 | MAPT (0.38) | L3MBTL1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL18961752 | 0.75 | GPR35 (0.53) | ERN1L3MBTL1MAPTSMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116134983-A | Organic light emitting device | 株式会社LG化学 | 2023-05-16 | — | — | CN | disclosed |
| CN-103534238-B | Total synthesis of redox active 1, 4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistosomimetics | 国家科研中心 | 2018-01-02 | — | — | CN | disclosed |
| US-8530138-B2 | Salt and photoresist composition comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-09-10 | — | — | US | disclosed |
| US-8524440-B2 | Photoresist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-09-03 | — | — | US | disclosed |
| US-20120052440-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20110318690-A1 | COMPOUND, RESIN AND PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110236827-A1 | RESIN AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110165513-A1 | PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY LTD (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110059400-A1 | PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-10 | — | — | US | disclosed |
| CN-1646527-A | Pharmaceutical comprising BETAMIMETICS and novel anticholinesterases | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-07-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052440-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | C1S, C1R, CLIC1 | PTPN22 961/4885LDHA 4876/4885ERN1 3636/4885 |
| US-20110059400-A1 | PHOTORESIST COMPOSITION | C1R, C1S, CCNT1 | PTPN22 4400/4885LDHA 4444/4885ERN1 3159/4885 |
| US-20110236827-A1 | RESIN AND PHOTORESIST COMPOSITION CONTAINING THE SAME | C1R, CBR1, RCOR1 | PTPN22 3629/4885LDHA 4231/4885ERN1 2515/4885 |
| US-20110318690-A1 | COMPOUND, RESIN AND PHOTORESIST COMPOSITION | RCOR1, C1R, C1S | PTPN22 4517/4885LDHA 4652/4885ERN1 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.